Guest authorship, mortality reporting, and integrity in rofecoxib studies - Reply

JAMA

Volumn 300, Issue 8, 2008, Pages 905-906

  DeAngelis, Catherine D ^a   Fontanarosa, Phil B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ROFECOXIB;

AUTHOR; ETHICS; FINANCIAL MANAGEMENT; LETTER; METHODOLOGY; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; STATISTICAL ANALYSIS; WRITING;

EID: 50449089848     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.8.905     Document Type: Letter

References (9)

1. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA. 2008;299(15):1800-1812.
2. Email communication from W. Hester Visser, MD, PhD, to Steven Ferris, PhD: September 12, 2003 [Bates No. MRK-AHD0015091 through MRK-AHD0015092]. http://dida.library.ucsf.edu/tid/vio18x10. Accessed June 26, 2008.
3. External author?, Visser WH, Yuen E, et al. DRAFT VERSION 2: rofecoxib does not delay the onset of Alzheimer's disease: results from a randomized, double-blind, placebo-controlled study [Bates No. MRK-AFV0431065 through MRK-AFV0431102]. http://dida.library.ucsf.edu/tid/vio07x10. Accessed June 26, 2008.
4. Flanagin A, Carey LA, Fontanarosa PB, et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA. 1998;280(3):222-224.
5. Mowatt G, Shirran L, Grimshaw JM, et al. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA. 2002;287(21):2769-2771.
6. Psaty BM, Kronmal RA. Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. JAMA. 2008;299(15):1813-1817.
7. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA. 2005;294(1):110-111.
8. JAMA instructions for authors. http://jama.ama-assn.org/ifora_current. dtl. Accessed July 21, 2008.
9. Fontanarosa PB, DeAngelis CD. Conflicts of interest and independent data analysis in industry-funded studies: reply. JAMA. 2005;294(20):2576-2577.